Latest News

Displaying articles 775 - 780 of 851 in total

Progressive MS Collaborative Launched

Thumbnail

International Progressive MS Collaborative established     The collaborative’s mission is to speed up the development of effective disease modifying and symptom management therapies for progressive forms of MS. Research to date, into treating progressive forms of m...

Published by MS Ireland on Friday August 10 2012 11:19 AM

View Article

Rehab Experiences Sought

Thumbnail

Help Improve rehabilitation services by taking this survey For many people with MS rehabilitation is an important part of managing the impact of the condition. Physiotherapy, occupational therapy and speech and language therapy can all play a part in maintaining or improving a persons functionin...

Published by MS Ireland on Tuesday July 31 2012 08:43 PM

View Article

Carers Strategy Launched

Thumbnail

Carers’ wellbeing, confidence and health are at the heart of the new National Carers Strategy. For carers in Ireland, this means recognition and acknowledgement of their role as key care partners. The first of its kind, the Strategy is welcomed by MS Ireland and carer organisations, for it...

Published by MS Ireland on Tuesday July 31 2012 08:15 PM

View Article

Gallop: MS Video

Thumbnail

The wonderful people over at shift.ms have created this fantastic video – watch here. Faced with life-changing news, would you believe in magic? Gallop: a story about what life can throw at us, and how we get back up. Shift.ms is a social network run by its users where young MSers mee...

Published by MS Ireland/Shift.ms on Tuesday July 31 2012 08:09 PM

View Article

FDA Consider Alemtuzumab

Thumbnail

For a number of years we have mentioned the possibility of a new drug called Alemtuzumab being a potential new treatment for people with MS. On 12 June 2012 the makers, Genzyme, announced that the company has made an official application to the Food and Drugs Administration (FDA) in the US and th...

Published by MS Ireland on Tuesday July 31 2012 07:29 PM

View Article

Gilenya Now Prescribed

Thumbnail

Fingolimod, under the trade name Gilenya, the first oral drug therapy for the treatment of MS, is now available under the direction of a neurologist. Gilenya is licensed as a second line therapy, making it suitable for people that have failed on conventional first line therapies or those individu...

Published by MS Ireland on Tuesday July 10 2012 11:21 AM

View Article


Latest News

More news

What's hot

Survey

Research Survey

What are the research priorities of the MS Community in Ireland? Have your say!

Find out more

Events Calendar

» Our next Event

22 August 2017: Ongoing Group physiotherapist led exercise classes for people with MS

View all events

eNEWS SIGNUP

If you'd like to receive e-news updates from The Society please enter your email address below. If you want to know more about how we manage personal data then please see our privacy policy.

My local MSI

Map of MS Ireland's service areas South Mid West West Midlands South East North East North West North Dublin City and Fingal South West Dublin and Kildare South East Dublin and Wicklow